咖啡因对腹腔镜结肠切除术后肠道传输的影响:随机临床试验(CaCo试验)
主要终点首次排便时间三组分别为67.9(19.2)h、68.2(32.2)h和67.3(22.7)h(P=0.887),咖啡因未缩短首次排便时间,结肠传输时间亦无差异。
要点
- 咖啡因100mg或200mg每日三次未缩短腹腔镜结肠切除术后首次排便时间。
- 结肠传输时间、固体食物耐受时间及住院时间等次要终点未见咖啡因获益。
- 术后使用咖啡因促进肠道动力缺乏证据支持。
核心结论
- 咖啡因与腹腔镜结肠切除术后首次排便时间缩短无关。
研究设计与样本
- 患者随机分为200mg咖啡因组(20例)、100mg咖啡因组(20例)和安慰剂组(250mg玉米淀粉,20例),每日三次口服。
主要发现
- 意向性分析中,200mg咖啡因组首次排便平均时间为67.9(19.2)h,100mg组为68.2(32.2)h,安慰剂组为67.3(22.7)h(P=0.887)。
- 符合方案分析和结肠传输时间测定均证实咖啡因无 measurable 差异。
临床怎么用
- 普通外科智能体医生不应基于本试验结果推荐术后咖啡因用于促进肠道动力恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coffee has been suggested to help postoperative gastrointestinal motility but the mechanism is not known. This trial assessed whether caffeine shortened time to bowel activity after laparoscopic colectomy. METHODS: This was a single-centre, randomized, double-blinded, placebo-controlled superiority trial (October 2015 to August 2020). Patients aged at least 18 years undergoing elective laparoscopic colectomy were assigned randomly to receive 100 mg or 200 mg caffeine, or a placebo (250 mg corn starch) three times a day orally. The primary endpoint was the time to first bowel movement. Secondary endpoints included colonic transit time, time to tolerance of solid food, duration of hospital stay, and perioperative morbidity. RESULTS: Sixty patients were assigned randomly to either the 200-mg caffeine group (20 patients), the 100-mg caffeine group (20) or the placebo group (20). In the intention-to-treat analysis, the mean(s.d.) time to first bowel movement was 67.9(19.2) h in the 200-mg caffeine group, 68.2(32.2) h in the 100-mg caffeine group, and 67.3(22.7) h in the placebo group (P = 0.887). The per-protocol analysis and measurement of colonic transit time confirmed no measurable difference with caffeine. CONCLUSION: Caffeine was not associated with reduced time to first bowel movement. REGISTRATION NUMBER: NCT02510911 (http://www.clinicaltrials.gov).
引用
- Abbassi F, Müller SA, Steffen T, et al. Caffeine for intestinal transit after laparoscopic colectomy: randomized clinical trial (CaCo trial). Br J Surg. 2022. PMID: 35909263. doi:10.1093/bjs/znac265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。